144 results on '"Yu, Oriana H. Y."'
Search Results
2. Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
Catalog
Books, media, physical & digital resources
3. Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population‐based cohort study.
4. Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom
5. Sodium‐glucose cotransporter‐2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
6. Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients With Type 2 Diabetes
7. Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study
8. Levothyroxine initiation and the risk of pregnancy loss among pregnant women with subclinical hypothyroidism: An observational study emulating a target trial.
9. Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes
10. The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
11. Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
12. Glucagon Like Peptide‐1 Receptor Agonists and the Risk of Skin Cancer Among Patients with Type 2 Diabetes: Population‐Based Cohort Study
13. Glucagon like peptide‐1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population‐based cohort study.
14. Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with Diabetes
15. SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials
16. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes
17. Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea:a nationwide cohort study
18. Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies.
19. SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population‐based Cohort Study
20. Long‐acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population‐based cohort study
21. Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population‐based cohort study
22. Additional file 1 of Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
23. Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population‐based cohort study
24. Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes.
25. Sodium‐glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population‐based cohort study.
26. Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
27. Incretin-based drugs and the risk of acute liver injury among patients with type 2 diabetes mellitus
28. Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
29. Response to: Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides
30. Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies
31. Additional file 1 of Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom
32. Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study
33. Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients with Type 2 Diabetes
34. Additional file 1 of Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study
35. Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population‐based assessment
36. Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003–2018
37. Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study.
38. Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes.
39. Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population-based assessment.
40. The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
41. Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism
42. Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
43. Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
44. Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes.
45. Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink.
46. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials.
47. Editorial commentary: Potential role of SGLT2 inhibitors in the management of hypertension.
48. Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study.
49. Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes.
50. Defining Clinically Relevant Target Populations Using Real-World Data to Guide the Design of Representative Antidiabetic Drug Trials.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.